6 insiders reported 50 Form 4 transactions for Dianthus Therapeutics, Inc. /DE/ (DNTH) over the past 18 months (most recent 2026-06-18). Recent activity: Veness Adam M (SVP, General Counsel and Sec.) Sell 16,771 shares, Veness Adam M (SVP, General Counsel and Sec.) Buy 30,000 shares, Veness Adam M (SVP, General Counsel and Sec.) Sell 13,229 shares, Randhawa Simrat (EVP, Head of R&D) Sell 5,428 shares, Randhawa Simrat (EVP, Head of R&D) Buy 6,908 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-18 | Veness Adam M | SVP, General Counsel and Sec. | Sell | 16,771 | $1.3M |
| 2026-06-18 | Veness Adam M | SVP, General Counsel and Sec. | Buy | 30,000 | $536,400 |
| 2026-06-18 | Veness Adam M | SVP, General Counsel and Sec. | Sell | 13,229 | $1.1M |
| 2026-06-02 | Randhawa Simrat | EVP, Head of R&D | Sell | 5,428 | $487,000 |
| 2026-06-02 | Randhawa Simrat | EVP, Head of R&D | Buy | 6,908 | $123,515 |
| 2026-06-02 | Randhawa Simrat | EVP, Head of R&D | Buy | 6,249 | $136,041 |
| 2026-06-02 | Randhawa Simrat | EVP, Head of R&D | Buy | 9,375 | $206,906 |
| 2026-06-02 | Randhawa Simrat | EVP, Head of R&D | Buy | 3,998 | $33,743 |
| 2026-06-02 | Randhawa Simrat | EVP, Head of R&D | Sell | 16,943 | $1.5M |
| 2026-06-02 | Randhawa Simrat | EVP, Head of R&D | Sell | 4,159 | $380,008 |
| 2026-05-11 | Soteropoulos Paula | Director | Buy | 599 | $5,056 |
| 2026-05-11 | Soteropoulos Paula | Director | Sell | 599 | $51,197 |
| 2026-04-10 | Savitz Ryan | EVP, CFO & CBO | Sell | 8,224 | $738,844 |
| 2026-04-10 | Savitz Ryan | EVP, CFO & CBO | Buy | 8,224 | $147,045 |
| 2026-03-26 | Soteropoulos Paula | Director | Buy | 27,594 | $232,893 |
| 2026-03-26 | Soteropoulos Paula | Director | Sell | 27,594 | $2.2M |
| 2026-03-17 | Garcia Marino | CEO AND PRESIDENT | Buy | 59,700 | $399,990 |
| 2026-03-17 | Garcia Marino | CEO AND PRESIDENT | Buy | 5,592 | $99,985 |
| 2026-03-13 | Randhawa Simrat | EVP, Head of R&D | Buy | 5,000 | $89,400 |
| 2026-03-13 | Randhawa Simrat | EVP, Head of R&D | Buy | 7,998 | $67,503 |
| 2026-03-13 | Garcia Marino | CEO AND PRESIDENT | Sell | 43,505 | $3.5M |
| 2026-03-13 | Randhawa Simrat | EVP, Head of R&D | Buy | 8,332 | $181,388 |
| 2026-03-13 | Randhawa Simrat | EVP, Head of R&D | Buy | 12,500 | $275,875 |
| 2026-03-13 | Randhawa Simrat | EVP, Head of R&D | Sell | 33,830 | $2.8M |
| 2026-03-13 | Garcia Marino | CEO AND PRESIDENT | Buy | 122,918 | $823,551 |
Source: SEC Form 4 filings · as of 2026-06-18